Scholar Rock Holding SRRK 深 滬
等待開盤 10-11 09:30:00 美东时间
39.46
-1.530
-3.73%
華盛通- 最 高41.42
- 今 開41.08
- 成交量 398.15万股
- 最 低 38.695
- 昨 收 40.99
- 總市值 37.93亿
- 52周最高 46.98
- 市盈率 靜 --
- 換手率 0.00%
- 52周最低 22.71
- 委 比 -78.33%
- 總股本 9612.73万
- 歷史最高 70.00
- 量 比 1.52
- 振 幅 6.65%
- 歷史最低 4.325
- 每 手 1
- 風險率 4.82%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股大行评级 | 潜在涨幅334.0%！HC Wainwright & Co.上调Inventiva目标价至24美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Inventiva"买入"评级，目标价从20美元升至24美元；摩根大通：维持BioMarin Pharmaceutical"超配"评级，目标价从116美元升至119美元
10-10 11:36
B of A Securities Initiates Coverage On Scholar Rock Holding with Buy Rating, Announces Price Target of $53
B of A Securities analyst Tazeen Ahmad initiates coverage on Scholar Rock Holding (NASDAQ:SRRK) with a Buy rating and announces Price Target of $53.
10-09 19:02
Crinetics Pharmaceuticals, BlackBerry, Perpetua Resources And Other Big Stocks Moving Higher On Friday
U.S. stocks were higher, with the Dow Jones index gaining more than 200 points on Friday. Shares of Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) rose sharply during Friday's session after the FDA approved PALSONIFY.
09-26 22:23
美股大行评级 | 217美元！花旗上调阿里巴巴目标价；多家机构集体上调麦克森、美光科技等目标价
今日重点评级关注：Ascendiant Capital：维持Maison Solutions"买入"评级，目标价从4美元升至4.25美元；瑞穗：维持MBX Biosciences"跑赢大市"评级，目标价从38美元升至56美元
09-25 09:52
Scholar Rock Holding (SRRK) Receives a Buy from Barclays
Barclays analyst Etzer Darout maintained a Buy rating on Scholar Rock Holding y...
09-24 08:15
Scholar Rock drops as FDA declines to approve lead drug
Scholar Rock (NASDAQ:SRRK) shares fell ~15% in the premarket on Tuesday after the biotech said that the U.S. FDA has issued a Complete Response Letter (CRL) in connection with its marketing applicatio...
09-23 19:45
Scholar Rock Faces FDA Setback for Apitegromab
The latest announcement is out from Scholar Rock Holding ( ($SRRK) ). On Septem...
09-23 19:29
美股大行评级 | Tigress Financial：维持苹果"强烈买入"评级，目标价升至305美元；杰富瑞维持百度"买入"评级，目标价升至157美元
今日重点评级关注：HC Wainwright & Co.：维持Astria Therapeutics"买入"评级，目标价从16美元升至20美元；HC Wainwright & Co.：维持Avalo Therapeutics"买入"评级，目标价从15美元升至25美元
09-18 10:13
Scholar Rock Holding shares are trading higher. Truist Financial maintained its Buy rating on the stock and Leerink initiated an Outperform rating on the stock as well.
Scholar Rock Holding shares are trading higher. Truist Financial maintained its...
09-16 03:03
Here's How Much $1000 Invested In Scholar Rock Holding 5 Years Ago Would Be Worth Today
Scholar Rock Holding (NASDAQ:SRRK) has outperformed the market over the past 5 ...
09-02 06:45
